Denosumab (Prolia) Prefilled Syringe from Japan
Denosumab (Prolia) is a human monoclonal antibody that inhibits RANKL, used for treating osteoporosis. It is supplied as a pre-filled syringe in measured doses for retail sale, qualifying under tariff item 3002.15.00 as an immunological product. This product regulates bone resorption through immunological modulation.
Duty Rate — Japan → Canada
0%
Import Tips
• Confirm the pre-filled syringe is in retail packaging with measured doses
• Have the certificate of analysis ready for CBSA inspection
• Verify if a Drug Identification Number is required by Health Canada